Autologous bone marrrow transplantation versus chemotherapy in relapsed/refractory non-hodgkin's lymphoma: Estimates of long-term survival from the recent literatur

This publication has 34 references indexed in Scilit:

• Cancer statistics, 1994
  CA: A Cancer Journal for Clinicians, 1994
• Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide.
  Journal of Clinical Oncology, 1993
• Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1993
• Effective salvage chemotherapy in relapsed or refractory non-Hodgkin's lymphoma
  Annals of Oncology, 1993
• A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma
  British Journal of Cancer, 1991
• Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: a Southwest Oncology Group study.
  Journal of Clinical Oncology, 1991
• Autologous bone marrow transplantation for non‐Hodgkin's lymphoma
  European Journal of Haematology, 1991
• Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.
  Journal of Clinical Oncology, 1991
• Improved survival of poor prognosis diffuse histiocytic (large cell) lymphoma managed with sequential induction chemotherapy, “boost” radiation therapy, and autologous bone marrow transplantation
  International Journal of Radiation Oncology*Biology*Physics, 1988
• Identification of Major Prognostic Subgroups of Patients with Large-Cell Lymphoma Treated with m-BACOD or M-BACOD
  Annals of Internal Medicine, 1986